Skip to main content
. 2023 Jun 20. Online ahead of print. doi: 10.1016/j.explore.2023.06.009

Table 4.

Findings of the reviewed studies

Study Citation Patient's characteristics Severity of disease Outcomes Components
Age Comorbidities Component Form Dose Duration
Farnoosh, et al25 50.7±14.4 Hypertension 33.3%
Diabetes 25%
Rheumatic disease 4.2%
Cardiovascular disease 12.5%
Cancer
Mild to moderate Clinical improvement of symptoms and laboratory parameters Melatonin Oral 3mg*3/day 14 days
Hasan ZT, et al 26 56.3±7.3 Hypertension 53.2%
Ischemic heart disease 15.8%
Asthma 29.7%
Severe thrombosis, sepsis, and mortality rate Melatonin Oral 10 mg 14 days
Marina Sánchez-Rico, et al 27 18–70
71–80
81+
diabetes mellitus
diseases of the circulatory system
diseases of the respiratory system
neoplasms and diseases of the blood
NA in-hospital all-cause mortality Melatonin Oral 2.61 mg
Ben Abdallah S et al 31 54.2 ± 17.3 NA Moderate *For inpatients: death, need for ICU admission and length of ICU and hospital stay at 30-day
*For outpatients: appearance of new symptoms, the need for hospitalization, need for ICU admission, and survival status
Zinc Oral 25 mg 15 days
Oneel Patel, et al32 59.8 ± 16.8 Hypertension
Diabetes
Chronic cardiovascular disease
Chronic respiratory Disease
Cirrhosis
Hepatic Failure
Moderate to severe In non‐ventilated patients was assessed as the level of oxygenation expressed as oxygen flow (in liters/min) required to maintain blood oxygen levels (SpO2) above 94% and the worst (lowest) PaO2/FiO2 ratio in ventilated patients Zinc IV 0.24 mg/kg/day 7 days
Margolin, et al33 45.2 (14.6) Diabetes
Hypertension
Dyslipidemia
Asthma
Mild
Outpatients
the number of days required to reach a 50% reduction in symptoms Vitamin C
Zinc
Oral *8000 mg of ascorbic acid (to be divided over 2-3 times per day)
*50 mg of zinc
10 days
Majidi, et al 35 59.42± 15 Severe Survival duration Vitamin C IV 500 mg 14 days
Poona Kumari, et al 36 52 ± 11 Moderate to severe *Days to be symptom-free
* Days spent in the hospital
* Need for mechanical ventilation
Vitamin C IV
Castillo ME, et al38 53.14 +/- 10.77 Lung disease
Diabetes mellitus
Hypertension
Cardiovascular disease
Moderate to Severe Rate of ICU admission and deaths Vitamin D Oral 0.532 mg
0.266 mg
0.266 mg
Day1
Day3
Day7
Igor H Murai, et al39 56.2 [14.4] Moderate to severe length of stay in hospital Vitamin D Oral 200 000 IU 1 day